Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: oxbryta
Pfizer is discontinuing its sickle cell disease treatment Oxbryta and withdrawing from markets approved due to risks of painful vaso-occlusive crisis and deaths seen in clinical trials, which found 8 deaths in those taking the drug vs 2 in placebo.
Subscribe to Updates
Subscribe to receive latest health related news from us
Copyright © Medical Channel Asia 2024.
All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.